Sciencedaily.com 9/6/2016
“… The loss of CHD1, one of the most frequently mutated genes in prostate tumors, sensitizes human prostate cancer cells to different drugs, including PARP inhibitors. …”
Read the entire article: https://www.sciencedaily.com/releases/2016/09/160905114802.htm
